INTERVIEW
Centerpiece of FPMAJ’s Lobbying Push Will Be Price Maintenance Premium: Chairman
The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) is poised to press for the permanent introduction of the so-called price maintenance premium for on-patent drugs as its top priority in discussions for the proposed drug pricing overhaul. The trade…
To read the full story
INTERVIEW
- Interview: Mathematician Changing the Future of Drug Discovery (FRONTEO CTO)
March 25, 2025
- From Treatment to Prevention, Top Expert on AD Research, Aducanumab and Its Implications - 2
February 8, 2021
- Alzheimer’s Treatment at Crossroads? Top Expert on AD Research, Aducanumab and Its Implications - 1
February 2, 2021
- Improper Materials Apparently Decreased after Promotion Guidelines Introduced: Pharmacist
February 10, 2020
- “Excessive Self-Restraint” of Promotion Activities by Drug Makers Hindering Drugs’ Lifecycle Management: Physician
January 28, 2020
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





